Literature DB >> 10404264

Enzyme immunoassay detection of Cryptosporidium parvum inhibition by sinefungin in sporozoite infected HCT-8 enterocytic cells.

G Gargala1, A Delaunay, L Favennec, P Brasseur, J J Ballet.   

Abstract

Complete parasite development was obtained in differentiated human enterocytic HCT-8 cells infected at confluence with Cryptosporidium parvum sporozoites, and evaluated in a quantitative enzyme immunoassay. Forty-eight hours after infection, a linear correlation was found between optical density values and the number of parasites determined in an immunofluorescent assay. Sinefungin exerted an inhibitory effect when added within 4 h after sporozoite addition to HCT-8 cultures (MIC50 = 38 mumol L-1), while the inhibitory effects of paromomycin and pentamidine dimethanesulfonate were also easily detected (MIC50 = 0.87 mumol L-1 and 0.27 mumol L-1, respectively). Except for high pentamidine dimethanesulfonate concentrations, no alteration in optical microscopy morphology or trypan blue exclusion of HCT-8 cells was observed in the presence of anticryptosporidial agents, which suggests that they were primarily active against developing parasites. Data suggest that EIA detection of C. parvum development in sporozoite-infected HCT-8 cells provides an accurate and convenient model for in vitro evaluation of parasite infectivity, growth and response to anticryptosporidial agents.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10404264     DOI: 10.1016/s0020-7519(99)00031-4

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  9 in total

Review 1.  Challenges in understanding the immunopathogenesis of Cryptosporidium infections in humans.

Authors:  R J Kothavade
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-12       Impact factor: 3.267

2.  Novel and promising compounds to treat Cryptosporidium parvum infections.

Authors:  Zofi Graczyk; Lidia Chomicz; Mariola Kozłowska; Zygmunt Kazimierczuk; Thaddeus K Graczyk
Journal:  Parasitol Res       Date:  2011-02-23       Impact factor: 2.289

3.  Application of quantitative real-time reverse transcription-PCR in assessing drug efficacy against the intracellular pathogen Cryptosporidium parvum in vitro.

Authors:  Xiaomin Cai; Keith M Woods; Steve J Upton; Guan Zhu
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

4.  Determination of pyrimidine dimers in Escherichia coli and Cryptosporidium parvum during UV light inactivation, photoreactivation, and dark repair.

Authors:  K Oguma; H Katayama; H Mitani; S Morita; T Hirata; S Ohgaki
Journal:  Appl Environ Microbiol       Date:  2001-10       Impact factor: 4.792

5.  Quantitative flow cytometric evaluation of maximal Cryptosporidium parvum oocyst infectivity in a neonate mouse model.

Authors:  A Delaunay; G Gargala; X Li; L Favennec; J J Ballet
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

6.  Characterization of an intestinal epithelial cell receptor recognized by the Cryptosporidium parvum sporozoite ligand CSL.

Authors:  R C Langer; D A Schaefer; M W Riggs
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

7.  Efficacy of pyrvinium pamoate against Cryptosporidium parvum infection in vitro and in a neonatal mouse model.

Authors:  Autumn S Downey; Curtis R Chong; Thaddeus K Graczyk; David J Sullivan
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

8.  Evaluation of new thiazolide/thiadiazolide derivatives reveals nitro group-independent efficacy against in vitro development of Cryptosporidium parvum.

Authors:  Gilles Gargala; Laetitia Le Goff; Jean-Jacques Ballet; Loic Favennec; Andrew V Stachulski; Jean-François Rossignol
Journal:  Antimicrob Agents Chemother       Date:  2010-01-04       Impact factor: 5.191

9.  A screening pipeline for antiparasitic agents targeting cryptosporidium inosine monophosphate dehydrogenase.

Authors:  Lisa Sharling; Xiaoping Liu; Deviprasad R Gollapalli; Sushil K Maurya; Lizbeth Hedstrom; Boris Striepen
Journal:  PLoS Negl Trop Dis       Date:  2010-08-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.